• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

献血者和高危人群中丙型肝炎病毒感染及IL28B基因多态性的患病率

Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.

作者信息

Soh Benjy Yi-Min, Kumar Rajneesh, Ekstrom Victoria Sze-Min, Lin Clement Yi-Hao, Thangaraju Sobhana, Tan Hwee Huang, Chan Kwai Peng, Choong Lina Hui Lin, Teo Diana, Chow Wan Cheng

机构信息

Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore.

Duke-NUS Medical School, Singapore.

出版信息

Singapore Med J. 2019 Jan;60(1):34-39. doi: 10.11622/smedj.2018078. Epub 2018 Jun 21.

DOI:10.11622/smedj.2018078
PMID:29926111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6351688/
Abstract

INTRODUCTION

To study the prevalence of hepatitis C virus (HCV) infection in blood donor (BD), haemodialysis (HD) and intravenous drug user (IVDU) populations in Singapore and assess the IL28B polymorphism if HCV positive.

METHODS

The BD population were healthy volunteers, the HD population were patients who were on haemodialysis for at least six months of follow-up between January 2009 and December 2014. IVDU population was from inmates at halfway houses who consented.

RESULTS

Between 2011 and 2014, of 161,658 individuals who underwent screening prior to blood donation, 95 (0.059%) were positive for HCV. Of the 42 sera available, common genotypes (GTs) were GT-3 (47.6%) and GT-1 (31.0%). Of 1,575 HD patients, 2.2% were anti-HCV positive. The HCV GT distribution was HCV GT-1 (32.4%), HCV GT-3 (20.5%) and GT-6 (8.8%). 83 halfway house inmates were screened. Of the 47 IVDUs, 36.2% were anti-HCV positive with predominant GT-3 (%). IL28B polymorphism was noted to be CC predominantly 85.3%.

CONCLUSION

Prevalence of HCV infection has decreased in both the BD and HD populations. However, it remains high in the IVDU population. GT-1 remains the most common in the HD population; however, GT-3 infection is now more common among the BD population in Singapore. IL28B - CC is the predominant variant among the HCV-infected individuals in Singapore.

摘要

引言

研究新加坡献血者(BD)、血液透析(HD)患者及静脉吸毒者(IVDU)人群中丙型肝炎病毒(HCV)感染的流行情况,并在HCV阳性者中评估IL28B基因多态性。

方法

献血者人群为健康志愿者,血液透析人群为2009年1月至2014年12月期间接受至少6个月随访的血液透析患者。静脉吸毒者人群来自同意参与的中途宿舍的 inmates。

结果

2011年至2014年期间,在161,658名献血前接受筛查的个体中,95人(0.059%)HCV呈阳性。在42份可用血清中,常见基因型(GTs)为GT-3(47.6%)和GT-1(31.0%)。在1575名血液透析患者中,2.2%抗-HCV呈阳性。HCV GT分布为HCV GT-1(32.4%)、HCV GT-3(20.5%)和GT-6(8.8%)。对83名中途宿舍 inmates 进行了筛查。在47名静脉吸毒者中,36.2%抗-HCV呈阳性,主要基因型为GT-3(%)。IL28B基因多态性主要为CC型,占85.3%。

结论

献血者和血液透析患者人群中HCV感染率均有所下降。然而,静脉吸毒者人群中的感染率仍然很高。GT-1在血液透析人群中仍然最常见;然而,GT-3感染目前在新加坡献血者人群中更为常见。IL28B - CC是新加坡HCV感染者中的主要变异型。

相似文献

1
Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.献血者和高危人群中丙型肝炎病毒感染及IL28B基因多态性的患病率
Singapore Med J. 2019 Jan;60(1):34-39. doi: 10.11622/smedj.2018078. Epub 2018 Jun 21.
2
IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.IL28B 基因多态性 rs12979860 而非 rs8099917 与乌拉圭患者慢性 HCV 感染的发生有关。
Virol J. 2018 Mar 2;15(1):40. doi: 10.1186/s12985-018-0946-2.
3
Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal.尼泊尔三个地区注射吸毒者中艾滋病毒、乙型和丙型肝炎感染率以及丙型肝炎病毒基因型和两个IL28B单核苷酸多态性的评估
PLoS One. 2015 Aug 11;10(8):e0134455. doi: 10.1371/journal.pone.0134455. eCollection 2015.
4
Impact of a single nucleotide polymorphism upstream of the IL28B gene in patients positive for anti-HCV antibody in an HCV hyperendemic area in Japan.日本 HCV 高度流行地区抗 HCV 抗体阳性患者中 IL28B 基因上游单核苷酸多态性的影响。
J Med Virol. 2014 Nov;86(11):1877-85. doi: 10.1002/jmv.24037. Epub 2014 Aug 7.
5
Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.丙型肝炎病毒:一组抗-HCV阳性法国献血者的感染途径和基因型
Vox Sang. 2000;79(3):138-44. doi: 10.1159/000031231.
6
IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors.IL28B 基因变异与抗 HCV 阳性献血者中 HCV 特异性 CD4(+) T 细胞应答。
J Viral Hepat. 2012 Dec;19(12):867-71. doi: 10.1111/j.1365-2893.2012.01631.x. Epub 2012 Jul 4.
7
IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.IL28B 基因变异和性别与丙型肝炎病毒感染的自发清除有关。
J Viral Hepat. 2012 Mar;19(3):173-81. doi: 10.1111/j.1365-2893.2011.01497.x. Epub 2011 Aug 4.
8
A study on the epidemiology of hepatitis C infection among blood donors in Singapore.新加坡献血者丙型肝炎感染的流行病学研究。
J Public Health Med. 1995 Dec;17(4):387-91.
9
Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody-positive blood donors in China.中国白细胞介素-28B 基因变异与丙型肝炎抗体阳性献血者的自发清除。
Transfusion. 2013 Oct;53(10 Pt 2):2498-504. doi: 10.1111/trf.12305. Epub 2013 Jun 19.
10
Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.丙型肝炎病毒特异性T细胞反应和IL28B rs12979860单核苷酸多态性基因型均影响慢性丙型肝炎患者的抗丙型肝炎病毒治疗结果。
J Interferon Cytokine Res. 2017 Jun;37(6):278-286. doi: 10.1089/jir.2016.0078. Epub 2017 Apr 25.

引用本文的文献

1
Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes.索磷布韦-维帕他韦治疗慢性丙型肝炎补贴决策对临床实践和患者结局的真实世界影响。
JGH Open. 2022 Nov 29;7(1):48-54. doi: 10.1002/jgh3.12850. eCollection 2023 Jan.
2
Study on the relationship between genetic polymorphism of reductive folic acid carrier and the risk of neural tube defects.还原叶酸载体基因多态性与神经管缺陷风险的关系研究。
Childs Nerv Syst. 2023 Jul;39(7):1711-1718. doi: 10.1007/s00381-022-05805-z. Epub 2022 Dec 20.
3
Systematic Review of Hepatitis C Virus Prevalence in the WHO Western Pacific Region.世界卫生组织西太平洋地区丙型肝炎病毒流行情况的系统评价。
Viruses. 2022 Jul 15;14(7):1548. doi: 10.3390/v14071548.
4
Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis.东南亚丙型肝炎病毒基因型和亚型的流行情况:系统评价和荟萃分析。
PLoS One. 2021 May 20;16(5):e0251673. doi: 10.1371/journal.pone.0251673. eCollection 2021.
5
What is required for achieving hepatitis C virus elimination in Singapore? A modeling study.在新加坡实现丙型肝炎病毒消除需要什么?一项建模研究。
J Gastroenterol Hepatol. 2021 Apr;36(4):1110-1117. doi: 10.1111/jgh.15211. Epub 2020 Sep 3.
6
Comment on: Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.关于《献血者和高危人群中丙型肝炎病毒感染率及IL28B基因多态性》的评论
Singapore Med J. 2019 Jun;60(6):323. doi: 10.11622/smedj.2019062.
7
Authors' reply.作者回复。
Singapore Med J. 2019 Jun;60(6):323. doi: 10.11622/smedj.2019063.
8
Factors Associated with Hepatitis B and C Co-Infection among HIV-Infected Patients in Singapore, 2006-2017.2006 - 2017年新加坡HIV感染患者中与乙型和丙型肝炎合并感染相关的因素
Trop Med Infect Dis. 2019 May 27;4(2):87. doi: 10.3390/tropicalmed4020087.

本文引用的文献

1
Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable polymorphism.聚乙二醇干扰素和利巴韦林在具有有利多态性的丙型肝炎1型人群中的真实世界经验。
Gastroenterol Rep (Oxf). 2017 Aug;5(3):208-212. doi: 10.1093/gastro/gow033. Epub 2016 Oct 24.
2
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.1990年至2013年病毒性肝炎的全球负担:全球疾病负担研究2013的结果。
Lancet. 2016 Sep 10;388(10049):1081-1088. doi: 10.1016/S0140-6736(16)30579-7. Epub 2016 Jul 7.
3
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.聚乙二醇干扰素联合利巴韦林治疗台湾初治急性或慢性丙型肝炎病毒感染的HIV感染者:一项前瞻性队列研究
Sci Rep. 2015 Nov 30;5:17410. doi: 10.1038/srep17410.
4
A 2015 roadmap for the management of hepatitis C virus infections in Asia.《2015年亚洲丙型肝炎病毒感染管理路线图》
Korean J Intern Med. 2015 Jul;30(4):423-33. doi: 10.3904/kjim.2015.30.4.423. Epub 2015 Jun 29.
5
Global distribution and prevalence of hepatitis C virus genotypes.丙型肝炎病毒基因型的全球分布与流行情况
Hepatology. 2015 Jan;61(1):77-87. doi: 10.1002/hep.27259. Epub 2014 Jul 28.
6
Epidemiology and natural history of HCV infection.丙型肝炎病毒感染的流行病学和自然史。
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):553-62. doi: 10.1038/nrgastro.2013.107. Epub 2013 Jul 2.
7
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.全球丙型肝炎病毒感染的流行病学:特定年龄组丙型肝炎病毒抗体血清流行率的新估计。
Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.
8
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.白细胞介素28B的基因变异与丙型肝炎病毒的自发清除
Nature. 2009 Oct 8;461(7265):798-801. doi: 10.1038/nature08463.
9
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.白细胞介素28B的基因变异可预测丙型肝炎治疗诱导的病毒清除情况。
Nature. 2009 Sep 17;461(7262):399-401. doi: 10.1038/nature08309. Epub 2009 Aug 16.
10
Treatment responses in Asians and Caucasians with chronic hepatitis C infection.亚洲和高加索慢性丙型肝炎感染者的治疗反应
World J Gastroenterol. 2008 Jun 7;14(21):3416-20. doi: 10.3748/wjg.14.3416.